Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 198,126,800
  • Shares Outstanding, K 1,734,455
  • Annual Sales, $ 40,109 M
  • Annual Income, $ 5,723 M
  • EBIT $ 8,588 M
  • EBITDA $ 11,831 M
  • 60-Month Beta 0.73
  • Price/Sales 4.86
  • Price/Cash Flow 17.67
  • Price/Book 4.87

Options Overview Details

View History
  • Implied Volatility 20.12% ( -2.28%)
  • Historical Volatility 12.32%
  • IV Percentile 53%
  • IV Rank 39.53%
  • IV High 29.56% on 10/08/24
  • IV Low 13.95% on 11/27/24
  • Put/Call Vol Ratio 1.52
  • Today's Volume 18,097
  • Volume Avg (30-Day) 8,265
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 231,733
  • Open Int (30-Day) 206,863

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.34
  • Number of Estimates 9
  • High Estimate 1.34
  • Low Estimate 1.33
  • Prior Year 1.19
  • Growth Rate Est. (year over year) +12.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
111.28 +2.65%
on 12/19/24
120.53 -5.23%
on 11/27/24
-1.70 (-1.47%)
since 11/20/24
3-Month
111.28 +2.65%
on 12/19/24
121.00 -5.60%
on 11/06/24
+0.53 (+0.47%)
since 09/20/24
52-Week
99.71 +14.56%
on 07/18/24
121.64 -6.09%
on 03/08/24
+6.83 (+6.36%)
since 12/20/23

Most Recent Stories

More News
My Top 10 Stocks to Buy for 2025

It's that time of year again. I'm not referring to buying gifts and preparing holiday meals -- although that may be part of your agenda too. It's time to look back on your portfolio's performance and plan...

NVDA : 134.70 (+3.08%)
VKTX : 42.25 (+1.83%)
CRWD : 362.29 (+3.21%)
ABT : 114.23 (+1.61%)
ETSY : 56.81 (-0.58%)
VRTX : 397.27 (+0.16%)
AXP : 298.65 (+1.90%)
AMZN : 224.92 (+0.73%)
PFE : 26.36 (+2.29%)
PLTR : 80.55 (+8.54%)
Medtronic Stock Declines 5.6% in a Month: Time to Buy the Dip?

Medtronic MDT closed at $79.99 in the last trading session, reflecting a 0.05% drop from the previous day. Broadly speaking, 2024 has not been smooth for investors in the Medical Products industry. Rising...

ABT : 114.23 (+1.61%)
BSX : 88.95 (+0.33%)
MDT : 81.03 (+1.30%)
2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond

What will be the hottest investing trend on Wall Street next year? Maybe artificial intelligence will keep up its momentum, or perhaps interest in weight loss-focused pharmaceutical companies will increase....

ABT : 114.23 (+1.61%)
ABBV : 175.58 (+2.37%)
BSX Trades Near 52-Week High: Does the Stock Hold More Potential?

Boston Scientific Corporation BSX remains in the spotlight, with its stock currently trading close to its 52-week high. In the past six trading sessions, the stock has consistently traded above $90.00...

ABT : 114.23 (+1.61%)
BSX : 88.95 (+0.33%)
MDT : 81.03 (+1.30%)
The Smartest Dividend Stocks to Buy With $500 Right Now

As an investor, your goal is to select quality stocks that will advance over a period of years -- but this doesn't mean you have to wait a long time for all of the rewards. If you add a few dividend stocks...

ABT : 114.23 (+1.61%)
KO : 62.55 (+0.16%)
JNJ : 144.47 (+0.62%)
Abbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta

/CNW/ -- Abbott (NYSE: ABT) today announced that the Government of Alberta has added Abbott's FreeStyle Libre 2* flash glucose monitoring system to the Alberta...

ABT : 114.23 (+1.61%)
How Abbott Labs Became a Dividend Growth Investor's Dream

Abbott Laboratories is one of the best dividend stocks to buy today: here's why.

ABT : 114.23 (+1.61%)
Is Medtronic Stock Underperforming the S&P 500?

Although Medtronic has lagged behind the broader S&P 500 index over the past three months, analysts remain moderately optimistic about the stock’s prospects.

ABT : 114.23 (+1.61%)
$SPX : 5,930.85 (+1.09%)
MDT : 81.03 (+1.30%)
Is Abbott Laboratories Stock Underperforming the Nasdaq?

Despite Abbott Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.

ABT : 114.23 (+1.61%)
$NASX : 19,572.60 (+1.03%)
JNJ : 144.47 (+0.62%)
Top Research Reports for Abbott, BlackRock & ConocoPhillips

Wednesday, November 27, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories...

BLK : 1,028.69 (+1.22%)
ABT : 114.23 (+1.61%)
TTE : 54.15 (+0.91%)
COP : 95.12 (-0.06%)
ITW : 258.82 (+0.28%)
PM : 124.22 (+1.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 117.98
2nd Resistance Point 116.54
1st Resistance Point 115.39
Last Price 114.23
1st Support Level 112.80
2nd Support Level 111.36
3rd Support Level 110.21

See More

52-Week High 121.64
Last Price 114.23
Fibonacci 61.8% 113.26
Fibonacci 50% 110.68
Fibonacci 38.2% 108.09
52-Week Low 99.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar